Dr. Annette Langer-Gould headshot

Annette Langer-Gould, MD, PhD, MS

Affiliated Investigator


Los Angeles Medical Center




Dr. Annette Langer-Gould is the regional lead for Translational Neuroscience for the Southern California Permanente Medical Group and a practicing multiple sclerosis specialist at the Kaiser Permanente Los Angeles Medical Center. Dr. Langer-Gould leads a team that develops, implements, and evaluates programs to provide high-quality, affordable care for individuals with MS and other neurologic diseases. She has been studying different aspects of MS susceptibility and prognosis for over 20 years. Her epidemiologic research focuses the comparative effectiveness and safety of rituximab and other MS treatments in a trial funded by the Patient-Centered Outcomes Research Institute in collaboration with the Swedish MS Registry. She also studys racial and ethnic disparities in MS outcomes and access to treatments.  Her past work has focused MS and pregnancy and on how the interplay between genotype and modifiable factors such as vitamin D, sun exposure and diet determines MS susceptibility and prognosis. Dr. Langer-Gould currently serves as a voting member on the California Technology Assessment Forum, a core program of the Institute for Clinical and Economic Review.


Areas of Focus

  • Multiple sclerosis susceptibility, prognosis and treatment
  • Comparative effectiveness and safety of treatments
  • Alzheimer's disease care models
  • Racial and ethnic disparities in MS


University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania
PhD, Epidemiology
Stanford University
Stanford, California
MS, Clinical Epidemiology
Stanford University
Stanford, California

Honors and Awards

Southern California Permanente Medical Group Clinical Trials Access Merit Award
Mentored Clinical Research Career Development Award (K23), National Institutes of Health, National Institute of Neurological Disorders and Stroke
Wadsworth Foundation Young Investigator’s Award
Plenary Session Speaker American Academy of Neurology’s 71st Annual Meeting, 2019